Related Experiment Videos
Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid
Laura Sowerby1, Anna K Dewan1, Scott Granter2
1The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
JAMA Dermatology
|March 30, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Spatial Transcriptomics and Mechanisms of Immune Checkpoint Inhibitor-Associated Interstitial Nephritis.
Kidney international reports·2026
Dermatologic Adverse Events Associated with T-Cell Engager Therapy.
American journal of clinical dermatology·2026
Longitudinal Growth in Children With Epidermal Differentiation Disorders.
JAMA dermatology·2026
Lived Experience of Hirsutism in Transfeminine Individuals.
JAMA dermatology·2026
From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott-Aldrich syndrome.
Regenerative medicine·2026
Primary extranodal marginal zone lymphoma of gastric mucosa-associated lymphoid tissue in children: a case report and review of the literature.
Journal of medical case reports·2026
Beyond MYD88-only testing: MYD88/CD79B profiling improves molecular detection and MCD genotyping in VRL and CNS lymphomas.
Experimental hematology & oncology·2026
Geranylgeranylation is required for B-cell proliferation and plasma cell survival implications for autoimmune therapy.
Cellular & molecular immunology·2026
A microbiota-driven CCL25-CCR9 axis reprograms intestinal ILC2s in the distal small intestine to promote metabolic dysfunction in obesity.
Cellular and molecular gastroenterology and hepatology·2026